Robert J. Jamnick serves as Executive at BIOSANTE PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Robert J. Jamnick has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 22, 2014 involved receiving (via award) 2,500 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| May 22, 2014 | ANIP] | $0 | Award | 2,500 | $N/A | Discretionary |
| Jun 19, 2013 | BPAX | $0 | Payment | 138,254 |
Robert J. Jamnick currently holds 48,118 shares of BIOSANTE PHARMACEUTICALS INC (BPAX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert J. Jamnick has been a net neutral trader of BPAX stock. They have purchased $0 and sold $0 worth of shares.
Robert J. Jamnick's most recent insider trade was on May 22, 2014, when they sold 2,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 19, 2013 | BPAX | $0 | Award | 411,964 | $N/A | Discretionary |